Portfolio company
48Hour Discovery
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a peptide discovery platform and screening services for pharmaceutical and biotechnology organisations to accelerate drug development.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Orbit Discovery
The company provides a peptide display platform for biotechnology and pharmaceutical partners to identify and optimise lead compounds for novel therapeutic drug development.
AilsynBio
This biotechnology company provides an artificial intelligence platform for peptide drug discovery and manufacturing services to pharmaceutical and healthcare organisations.
Protillion Biosciences
This company develops a high-throughput protein engineering platform for pharmaceutical partners to accelerate the discovery and optimisation of therapeutic antibodies and binder drugs.
Dash Bio
This company provides automated bioanalysis assays and laboratory services for pharmaceutical firms and biotechnology startups to accelerate sample analysis and drug development.
Gyros Protein Technologies
The company provides peptide synthesisers and microfluidic immunoassay platforms for biopharmaceutical researchers and manufacturers to accelerate drug discovery, development and bioprocessing.
AAX Biotech
This company develops antibody engineering technologies for epitope mapping and fragment stabilisation to support pharmaceutical and biotechnology firms in drug discovery.
Meddenovo
This company develops an artificial intelligence platform for de novo cyclic peptide drug discovery to support pharmaceutical and biotechnology firms.
NuvoBio
The company provides artificial intelligence software to design target-specific peptide therapeutics for pharmaceutical and biotechnology organisations.
